Johnson & Johnson - Change In Other Working Capital
Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Change-In-Other-Working-Capital" stands at 0.356 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2024, the highest value since 03/31/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.26 Billion United States Dollars compared to the value the year prior.
The 1 year change is 7.26 Billion United States Dollars.
The 3 year change is 1.84 Billion United States Dollars.
The 5 year change is 1.23 Billion United States Dollars.
The 10 year change is 2.29 Billion United States Dollars.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2023, to it's latest available value, on 06/30/2024, is +7.94 Billion.
The Serie's change in United States Dollars from it's maximum value, on 06/30/2015, to it's latest available value, on 06/30/2024, is -1.25 Billion.
Change In Other Working Capital for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Change In Other Working Capital | 905,699,262,464.00 |
 | AbbVie Inc - Change In Other Working Capital | 399,570,305,024.00 |
 | Roche Holding AG - Change In Other Working Capital | 317,433,206,677.55 |
 | AstraZeneca PLC - Change In Other Working Capital | 280,205,508,085.11 |
 | Novartis AG - Change In Other Working Capital | 255,096,620,580.91 |